Purchases and Sales Made in Q1 2024 in I Teos Therapeutics, Inc. (ITOS)
This table provides information about the institutional ownership of I Teos Therapeutics, Inc. (ITOS) during Q1 2024. The information is specifically focused on institutions that hold shares of iTeos Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-45.5K- 54.93% |
$450K - $620K
|
37.3K
$236K
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-48.8K- 14.16% |
$483K - $666K
|
296K
$1.87M
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-52.1K- 68.88% |
$516K - $711K
|
23.6K
$149K
|
|
May 06, 2024
Q1 2024
|
Empowered Funds, LLC
|
SELL
|
- |
-52.4K- 47.5% |
$518K - $715K
|
57.9K
$366K
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-63.3K- 52.23% |
$626K - $864K
|
57.9K
$366K
|
|
May 10, 2024
Q1 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-78.8K- 91.9% |
$779K - $1.07M
|
6.94K
$43.9K
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-84.4K- 8.73% |
$835K - $1.15M
|
883K
$5.58M
|
|
May 14, 2024
Q1 2024
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-86.1K- 39.12% |
$851K - $1.17M
|
134K
$847K
|
|
May 14, 2024
Q1 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-101K- 29.48% |
$1M - $1.38M
|
242K
$1.53M
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-147K- 3.45% |
$1.45M - $2M
|
4.11M
$26M
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-245K- 70.76% |
$2.42M - $3.34M
|
101K
$640K
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-260K- 91.17% |
$2.57M - $3.55M
|
25.2K
$159K
|
|
May 15, 2024
Q1 2024
|
Saturn V Capital Management LLC
Austin, TX |
SELL
|
- |
-441K- 53.26% |
$4.36M - $6.02M
|
387K
$2.45M
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-450K- 96.2% |
$4.45M - $6.13M
|
17.8K
$112K
|